According to the report, the Chronic Heart Failure CHF Devices Market provides the best answers to many of the most critical questions and challenges in the business world. In addition, the data facts …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Roche sees fall in FY23 earnings on ‘sharp decline’ in COVID products sales - February 2, 2023
- Roche Holding Non-GAAP EPS of CHF20.30, revenue of CHF63.28B - February 2, 2023
- F. Hoffmann-La Roche Ltd: Roche reports good results for 2022 despite decline in demand for COVID-19 products - February 2, 2023